Drug intelligence / Profile preview

Tulsi Amrit

Development stage: Unknown
Lead developer: Tulsi Amrit
Administration: Oral

Overview

Tulsi Amrit is a consumer herbal supplement and traditional Ayurvedic formulation developed and manufactured by Paawan Herbal. It is marketed as a concentrated extract derived from multiple varieties of the Tulsi plant (Holy Basil, *Ocimum sanctum*). As a patented consumer product rather than a pharmaceutical drug candidate, it does not have defined molecular targets or clinical development phases in the conventional biotech sense. It is typically used for immune support and respiratory health and is administered orally, often in the form of liquid drops.

Brand names: Tulsi Amrit

Targets

GABRR (GABA-A receptor subunit rho)NaV (Voltage-gated sodium channels)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ER (Estrogen receptor)

Beyond the preview

Go deeper on Tulsi Amrit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tulsi Amrit.

Explore the full profile